Evidence map›Paper›PMID 42151659›Full record

ArticleJournal of imaging informatics in medicine2026

A Fluorescence Imaging- and Deep Learning-Based Approach for Detecting Hepatitis B Virus Integration into Host Genomes.

Tzu-Hsien Yang, Wen-Tai Chiu, Yun-Hsuan Chu, Han-Ting Hong, Cheng-Wei Liu, Lian-Yun Chang, Hsu-Chin Hung, Wei-Cheng Dai, Yi-Lin Chen, Sern Yan Lim and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of imaging informatics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tzu-Hsien Yang *Department of Biomedical Engineering, Medical Device Innovation Center, National Cheng Kung University, Tainan, Taiwan.
Wen-Tai Chiu *Department of Biomedical Engineering, Medical Device Innovation Center, National Cheng Kung University, Tainan, Taiwan.
Yun-Hsuan ChuDepartment of Medical Laboratory Science and Biotechnology, National Cheng Kung University, Tainan, Taiwan.
Han-Ting Hong *Department of Electrical Engineering, National Cheng Kung University, Tainan, Taiwan.
Cheng-Wei Liu *Department of Electrical Engineering, National Cheng Kung University, Tainan, Taiwan.
Lian-Yun ChangDepartment of Biomedical Engineering, Medical Device Innovation Center, National Cheng Kung University, Tainan, Taiwan.
Hsu-Chin HungDepartment of Medical Laboratory Science and Biotechnology, National Cheng Kung University, Tainan, Taiwan.
Wei-Cheng DaiDepartment of Biomedical Engineering, Medical Device Innovation Center, National Cheng Kung University, Tainan, Taiwan.
Yi-Lin ChenDepartment of Pathology, National Cheng Kung University Hospital, Tainan, Taiwan.
Sern Yan LimDepartment of Biotechnology and Bioindustry Sciences, National Cheng Kung University, Tainan, Taiwan.
Yu-Ching ChuangDepartment of Biotechnology and Bioindustry Sciences, National Cheng Kung University, Tainan, Taiwan.
Wenya HuangDepartment of Medical Laboratory Science and Biotechnology, National Cheng Kung University, Tainan, Taiwan. whuang@mail.ncku.edu.tw.
Tsunglin LiuDepartment of Biotechnology and Bioindustry Sciences, National Cheng Kung University, Tainan, Taiwan. tsunglin@mail.ncku.edu.tw.ORCID http://orcid.org/0000-0002-1026-1605

Funding

National Science and Technology Council NSTC 113-2221-E-006-194-MY
6 · The paper itself

Abstract

Hepatitis B virus (HBV) infection can lead to hepatocellular carcinoma, and HBV integration into the host genome is regularly observed in the liver of chronic HBV carriers and is speculated to trigger carcinogenesis. To detect HBV integration, PCR-based methods are sensitive but may not be effective depending on the HBV integration site. High-throughput sequencing reveals not only HBV integration but also the site. However, it is still expensive for clinical applications. In situ hybridization is efficient and allows detection of DNA and RNA in single cells and has been applied to study HBV infection and dynamics. The technique, however, has not been applied to detect HBV integration. The task is challenging because of the small copy number of integrated HBV genomes, which results in a small signal-to-noise ratio. Here, we developed a fluorescence in situ hybridization approach for examining HBV integration in each liver cell. The obtained images of cells were analyzed using a deep learning model. Using several hepatoma cell lines with and without integrated HBV DNA, we showed that our trained neural network achieved an over 90% accuracy for majority of positive and negative control cells. This is the first proof-of-concept study showing that fluorescence imaging and deep learning are useful in detecting HBV integration at the single-cell level.

Indexed as

Deep learningFluorescent in situ hybridization (FISH)HBV integrationHepatitis B virus (HBV)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.